-
ESMA seeks clearer communication of ESG strategy to investors
Lack of transparency on specific strategies such as ESG integration and ESG exclusions poses a greenwashing risk.
-
ESG US roundup: Federal power, state pushback, and energy policy fault lines
How ESG debates are shifting from high-level commitments to concrete disputes over permits, costs, and regulatory power.
-
GRIP Forecast 2026 – ESG
The GRIP team looks at the prospects for the ESG agenda in 2026.
-
EFRAG publishes draft simplified European Sustainability Reporting Standards
The EC is aiming to adopt this delegated act in late 2026, applying to in-scope entities in respect of financial year 2027.
-
PRA finalizes climate risk expectations
The PRA has issued a principles-based, proportionate framework of expectations for firms to manage climate-related financial risk.
-
FCA consults on ESG ratings regime
The proposals address well-documented concerns about opacity, reliability, and independence in the ESG ratings market.
-
Fujifilm blazes a trail through pharma’s ethical quagmire
As advancements in research and drug development become more complex, bioethicists are helping companies find their footing along an increasingly ambiguous path.
-
Global coalition of funders commits $300m to climate and health solutions
The Climate and Health Funders Coalition will support innovations, policies, and research on environmental hazards and climate-sensitive infectious diseases.